# Neuropsychiatric Systemic Lupus Erythematosus: A Case Series

**Authors:** Manuel A Garcia-Smester, Asha Patnaik

PMC · DOI: 10.7759/cureus.99634 · Cureus · 2025-12-19

## TL;DR

This paper presents three unique cases of neuropsychiatric lupus to highlight the challenges in diagnosing and treating this rare condition.

## Contribution

The novelty lies in showcasing distinct NPSLE presentations and their management in a case series format.

## Key findings

- Three female patients presented with varied NPSLE manifestations including acute confusional state, cerebral vasculitis, and catatonia.
- Treatment strategies included corticosteroids and immunosuppressants, with mixed clinical outcomes.
- NPSLE diagnosis remains challenging due to its heterogeneity and lack of biomarkers.

## Abstract

Neuropsychiatric systemic lupus erythematosus (NPSLE) is a rare and poorly understood manifestation of systemic lupus erythematosus, encompassing a wide range of neurological and psychiatric symptoms. In order to highlight the diagnostic complexity and therapeutic challenges of NPSLE, this report presents the management of three distinct presentations. We retrospectively reviewed cases of three female patients with NPSLE admitted to a tertiary care hospital. Clinical presentation, diagnostic workup, treatment strategies, and outcomes were analyzed. Each case demonstrated unique NPSLE manifestations: acute confusional state in the setting of sepsis, cerebral vasculitis with retinal involvement, and catatonia. Treatments included high-dose corticosteroids, cyclophosphamide, and mycophenolate mofetil, with varying degrees of clinical improvement. NPSLE remains a diagnostic challenge due to its heterogeneity and lack of definitive biomarkers. Early recognition and individualized immunosuppressive treatment are essential for improved outcomes.

## Linked entities

- **Chemicals:** cyclophosphamide (PubChem CID 2907), mycophenolate mofetil (PubChem CID 5281078)
- **Diseases:** systemic lupus erythematosus (MONDO:0007915), neuropsychiatric systemic lupus erythematosus (MONDO:0043985), catatonia (MONDO:0800105)

## Full-text entities

- **Diseases:** cerebral vasculitis (MESH:D020293), catatonia (MESH:D002389), confusional (MESH:D003221), NPSLE (MESH:D020945), sepsis (MESH:D018805), neurological (MESH:D009461), retinal involvement (MESH:D012173), systemic lupus erythematosus (MESH:D008180), psychiatric (MESH:D001523)
- **Chemicals:** cyclophosphamide (MESH:D003520), mycophenolate mofetil (MESH:D009173)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12812321/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12812321/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12812321/full.md

---
Source: https://tomesphere.com/paper/PMC12812321